Wall Street Experts
ver. ZuMIgo(08/25)
Clinuvel Pharmaceuticals Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 166
EBIT TTM (mln): 94
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
Rok finansowy |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
3 |
3 |
7 |
17 |
25 |
31 |
33 |
48 |
66 |
78 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
505.7% |
-62.5% |
-100.0% |
0.0% |
0.0% |
inf% |
-30.6% |
114.9% |
71.5% |
24.6% |
105.6% |
145.8% |
52.0% |
21.8% |
4.9% |
47.3% |
37.0% |
19.2% |
Marża brutto |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
100.0% |
100.0% |
-237.9% |
-inf% |
-inf% |
0.0% |
100.0% |
100.0% |
89.3% |
86.0% |
-78.1% |
71.6% |
96.3% |
96.3% |
98.6% |
56.6% |
73.4% |
70.9% |
64.6% |
EBIT (mln) |
0 |
-2 |
-4 |
-5 |
-9 |
-12 |
-11 |
-11 |
-19 |
-18 |
-16 |
-13 |
-10 |
-8 |
-6 |
-11 |
-4 |
7 |
12 |
17 |
10 |
27 |
33 |
41 |
EBIT Δ r/r |
0.0% |
-inf% |
112.8% |
17.3% |
78.0% |
41.2% |
-11.6% |
3.4% |
67.2% |
-3.5% |
-10.0% |
-22.3% |
-19.0% |
-19.7% |
-29.6% |
85.7% |
-67.2% |
-291.5% |
79.6% |
36.6% |
-38.9% |
161.8% |
23.9% |
23.7% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-9893.8% |
-1444.3% |
-3979.4% |
0.0% |
0.0% |
0.0% |
-1222.9% |
-1425.9% |
-533.2% |
-218.9% |
-326.3% |
-52.0% |
40.6% |
47.9% |
53.8% |
31.3% |
55.6% |
50.3% |
52.2% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
3 |
EBITDA (mln) |
0 |
-2 |
-3 |
-4 |
-8 |
-12 |
-9 |
-10 |
-18 |
-17 |
-16 |
-13 |
-10 |
-8 |
-6 |
-11 |
-4 |
7 |
12 |
17 |
11 |
28 |
34 |
42 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-9232.7% |
-1160.3% |
-3617.2% |
0.0% |
0.0% |
0.0% |
-1214.1% |
-1417.2% |
-529.5% |
-217.5% |
-325.5% |
-51.7% |
40.9% |
48.1% |
54.1% |
32.7% |
57.4% |
51.5% |
53.2% |
Podatek (mln) |
-0 |
-2 |
-3 |
-4 |
-8 |
-11 |
-0 |
-3 |
-5 |
-3 |
-2 |
-1 |
-1 |
-0 |
0 |
-0 |
-1 |
-0 |
0 |
0 |
-4 |
1 |
13 |
15 |
Zysk Netto (mln) |
0 |
-2 |
-3 |
-4 |
-8 |
-11 |
-11 |
-9 |
-15 |
-15 |
-12 |
-11 |
-10 |
-7 |
-6 |
-10 |
-3 |
7 |
13 |
18 |
17 |
25 |
21 |
31 |
Zysk netto Δ r/r |
0.0% |
-inf% |
101.6% |
26.6% |
90.9% |
45.3% |
-2.4% |
-14.8% |
59.7% |
4.9% |
-25.1% |
-1.0% |
-14.4% |
-30.4% |
-18.8% |
88.2% |
-70.0% |
-330.1% |
84.2% |
37.1% |
-8.2% |
48.5% |
-15.6% |
46.6% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-8850.0% |
-1426.6% |
-3238.9% |
0.0% |
0.0% |
0.0% |
-1096.0% |
-1351.3% |
-438.0% |
-207.5% |
-313.4% |
-45.8% |
42.8% |
51.9% |
58.4% |
51.1% |
51.5% |
31.8% |
39.1% |
EPS |
0.0 |
-0.22 |
-0.35 |
-0.44 |
-0.66 |
-0.84 |
-0.64 |
-0.37 |
-0.48 |
-0.51 |
-0.38 |
-0.38 |
-0.32 |
-0.19 |
-0.14 |
-0.24 |
-0.0689 |
0.15 |
0.28 |
0.38 |
0.31 |
0.5 |
0.42 |
0.62 |
EPS (rozwodnione) |
0.0 |
-0.22 |
-0.35 |
-0.44 |
-0.66 |
-0.84 |
-0.64 |
-0.37 |
-0.48 |
-0.51 |
-0.38 |
-0.38 |
-0.32 |
-0.19 |
-0.14 |
-0.24 |
-0.0689 |
0.14 |
0.27 |
0.37 |
0.3 |
0.48 |
0.4 |
0.59 |
Ilośc akcji (mln) |
9 |
7 |
9 |
9 |
11 |
13 |
17 |
25 |
30 |
30 |
30 |
30 |
31 |
35 |
39 |
43 |
45 |
48 |
48 |
48 |
49 |
49 |
49 |
49 |
Ważona ilośc akcji (mln) |
9 |
7 |
9 |
9 |
11 |
13 |
17 |
25 |
30 |
30 |
30 |
30 |
31 |
35 |
39 |
43 |
45 |
50 |
50 |
50 |
50 |
51 |
52 |
52 |
Waluta |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |
AUD |